Cited by 423Metabolism, Diabetes, and CancerGlycogen Storage Diseases and MyoclonusBiochemical and Molecular Research

AMPK β Subunit Targets Metabolic Stress Sensing to Glycogen

Open access
Polekhina, Galina, Gupta, Abhilasha, Michell, Belinda J., van Denderen, Bryce, Murthy, Sid, Feil, Susanne C., Jennings, Ian G., Campbell, Duncan J. +4 more·2003·Current Biology

Abstract

AMP-activated protein kinase (AMPK) is a multisubstrate enzyme activated by increases in AMP during metabolic stress caused by exercise, hypoxia, lack of cell nutrients, as well as hormones, including adiponectin and leptin. Furthermore, metformin and rosiglitazone, frontline drugs used for the treatment of type II diabetes, activate AMPK. Mammalian AMPK is an alphabetagamma heterotrimer with multiple isoforms of each subunit comprising alpha1, alpha2, beta1, beta2, gamma1, gamma2, and gamma3, which have varying tissue and subcellular expression. Mutations in the AMPK gamma subunit cause glycogen storage disease in humans, but the molecular relationship between glycogen and the AMPK/Snf1p kinase subfamily has not been apparent. We show that the AMPK beta subunit contains a functional glycogen binding domain (beta-GBD) that is most closely related to isoamylase domains found in glycogen and starch branching enzymes. Mutation of key glycogen binding residues, predicted by molecular modeling, completely abolished beta-GBD binding to glycogen. AMPK binds to glycogen but retains full activity. Overexpressed AMPK beta1 localized to specific mammalian subcellular structures that corresponded with the expression pattern of glycogen phosphorylase. Glycogen binding provides an architectural link between AMPK and a major cellular energy store and juxtaposes AMPK to glycogen bound phosphatases.

Integrity signals

Registry

Crossref · 10.1016/s0960-9822(03)00292-6

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The CBM is closely related to isoamylase domains found in glycogen and starch branching enzymes.

    “The CBM is closely related to isoamylase domains found in glycogen and starch branching enzymes [129].”

    From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [129]

  • The AMPK β subunits contain a central domain, referred to as the carbohydrate-binding motif (CBM) or glycogen-binding domain that allows AMPK to bind to glycogen.

    “In regards to AMPK, the AMPK β subunits contain a central domain, referred to as the carbohydrate-binding motif (CBM) or glycogen-binding domain that allows AMPK to bind to glycogen [129].”

    From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [129]

  • The CBM is highly conserved between isoforms and across species, ranging from mammals, fruitfly, worm, yeast, and plants.

    “This domain is highly conserved between isoforms and across species, ranging from mammals, fruitfly (Drosophila melanogaster), worm (Caenorhabditis elegans), yeast (Saccharomyces cerevisiae), and plants [129].”

    From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [129]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Polekhina, G., Gupta, A., Michell, B. J., van Denderen, B., Murthy, S., Feil, S. C., Jennings, I. G., Campbell, D. J., Witters, L. A., Parker, M. W., Kemp, B. E., & Stapleton, D.
Affiliations
  • The University of Melbourne (AU)
  • Dartmouth College (US)
Corresponding author
Stapleton, David
Venue
Current Biology
Publisher
Elsevier BV
Published
2003-05
Volume
13
Issue
10
Pages
867-871
ISSN
0960-9822 (ISSN-L)
OpenAlex
W2027815803
Cited by
423
References
30
Citations by year
2026: 5 · 2025: 9 · 2024: 6 · 2023: 3 · 2022: 14 · 2021: 17 · 2020: 14 · 2019: 12 · 2018: 14 · 2017: 19 · 2016: 19 · 2015: 24 · 2014: 16 · 2013: 22 · 2012: 26
FWCI
9.08
Type
journal article
Language
en
Open access
Locations
  • Current Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK-35712, R01DK035712)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
Keywords
AMPK, glycogen, glycogen phosphorylase, glycogen storage disease, type 2 diabetes, metformin, rosiglitazone
MeSH terms
Amino Acid Sequence, Animals, Glycogen, Glycogen Synthase, Models, Molecular, Molecular Sequence Data, Multienzyme Complexes, Phylogeny, Protein Binding, Stress, Physiological, Gene Expression, Protein Serine-Threonine Kinases, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Protein Subunits, Glycogen Phosphorylase, Rats, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review